Format

Send to:

Choose Destination
See comment in PubMed Commons below
Biotechnol Appl Biochem. 1998 Oct;28 ( Pt 2):119-24.

Renaturation of recombinant human neurotrophin-3 from inclusion bodies using a suppressor agent of aggregation.

Author information

  • 1Biotechnology Laboratories, Pharmaceutical Research Division, Takeda Chemical Industries Ltd, Jusohonmachi 2-17-85, Yodogawa-ku, Osaka 532, Japan.

Abstract

Escherichia coli has been widely used in the production of recombinant proteins. One of the drawbacks inherent in this method is that the proteins produced in the cells often form inactive inclusion bodies. Usually, the inclusion bodies can be separated from other cell components, solubilized by denaturants such as guanidine hydrochloride or urea, and then renatured through a refolding process such as dilution or dialysis. However, it has been shown that biologically active recombinant human neurotrophin-3 cannot be obtained at high yield by this procedure due to aggregation and precipitation of the protein. We applied the refolding process using the aggregation suppressor L-arginine in the renaturation of neurotrophin-3, and obtained biologically active neurotrophin-3 at high yield from the inclusion bodies. Consequently, about 10 mg of purified neurotrophin-3 was prepared from 1 litre of culture broth.

PMID:
9756741
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk